TRP Starter Grant: Side effect profiling of the MIF-targeting chemokine receptor peptide mimic msR4M-L1: a novel drug approach for atherosclerotic diseases
| Institution | Technische Universität München |
|---|---|
| Project leader | Aphrodite Kapurniotu |
| Site | München |
| Project type | Translational Research Project |
| Funding | € 35.000,00 |
| Begin | 01.01.2026 |
| End | 30.06.2027 |
| Partnerprojekte |
Förderkennzeichen
81X2600424
Projektnummer
2151